For too long, the industry believed that deeper needle penetration meant better results. Dr Christie-Schwarz challenged this misconception, explaining that our knowledge of skin anatomy shows otherwise.

• Target the Dermis: Fibroblasts, the key cells responsible for collagen production, are primarily located in the dermis, which accounts for approximately 85% of the skin's structure. The hypodermis, by comparison, accounts for only 5-7%. Maximise collagen production by focusing on the dermal layer.

• Localised Regeneration: As research shows, the regenerative process activates at the very end of the needle, not along its entire length. This means precise targeting is essential for the best outcomes.

• New Collagen Formation: Find that new collagen forms just 0.6mm from the surface of the skin. Working too deeply can miss this vital area.

Dermapen 4® enables practitioners to treat a broader range of conditions than ever before. It is time to go beyond traditional collagen induction therapy to provide comprehensive solutions for modern patient needs, such as:

• Epidermal Applications: Superficial procedures target epidermal growth factors, effectively treating conditions such as comedones, milia, acne, hyperpigmentation, and hypopigmentation.

• Dermal Rejuvenation: Treat rosacea and telangiectasia, and achieve powerful anti-aging benefits, including the reduction of both deep and superficial wrinkles.

• Scar and Stria Revision: Address post-acne scars, keloids, burn contraction scars, and stria with targeted approaches, achieving mechanical revision of older, bound scars while regenerating new collagen.

The Dermapen 4® device offers unparalleled infusion capabilities:

• Unprecedented Puncture Channels: At top speed, the Dermapen 4® creates an astounding 1,920 puncture channels per second. This mechanical force effectively drives active solutions into the skin, ensuring greater administration, saturation, and distribution.

• Dp Dermaceuticals MG Collection™: Featuring exosome technology and Uber Pro/MD, overcomes the traditional limitations of patient age, diet, lifestyle, environment, and disease, providing a powerful, non-donor-dependent chemical regenerative therapy.

• Enhanced Delivery: Experience significantly greater delivery potential compared to outdated methods such as iontophoresis, electroporation, or traditional ultrasound therapy.

Dermapen 4 stands apart from radiofrequency (RF) microneedling, offering a safer and more versatile approach.

• No Heat, No Ablation: Dermapen 4® operates without heat, making it a non-thermolytic and non-ablative device. This preserves the integrity of active ingredients, such as exosomes, proteins, and peptides, which can be denatured by heat.

• Optimised Ingredient Integrity: Safely deliver non-donor-dependent chemical regenerative agents into the skin, maintaining their efficacy.

• True regenerative cascade: Genuine regenerative process, maximising the potential of fibroblasts within the dermis for superior results across all skin types and ethnicities.